Edwards Lifesci

EW NYSE
219.34
+4.13
+1.92%
After Hours: 220.94 +1.6 +0.73% 18:42 08/16 EDT
Open
218.00
Prev Close
215.21
High
220.48
Low
217.19
Volume
1.08M
Avg Vol (3M)
1.28M
52 Week High
220.48
52 Week Low
136.44
% Turnover
0.52%
Market Cap
45.62B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Edwards Lifesci EW stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
MORE >

Recently

Name
Price
%Change